2 No-Brainer Healthcare Stocks to Buy Now
The obesity drug market is creating trillion-dollar winners, but you don't have to pay premium prices for exposure. (NYSE: PFE) and Viking Therapeutics (NASDAQ: VKTX) are both relatively inexpensive compared to their opportunities in obesity. One offers a high-yield blue chip that just spent $10 billion entering the space, while the other is a pure-play biotech with late-stage programs in both injectable and oral weight-loss drugs.
Here's why these two healthcare stocks scan as no-brainer buys right now.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Aktie
23,43 €
1,49 %
Die Pfizer Inc. Aktie erhält eine Reihe von Buy-Einschätzungen, die die Sell-Zahlen übertreffen.
Ein leicht positives Kursziel von 27 € für Pfizer Inc. gegenüber dem aktuellen Kurs von 23.43 € wird gesehen.
